In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Maxim Pharmaceuticals Inc.

Division of Immune Pharmaceuticals Inc.
www.maxim.com

Latest From Maxim Pharmaceuticals Inc.

Germany's Growth Story

Germany's biotech investment has propelled a handful of companies onto the public markets a lot sooner than their US or UK counterparts. These German companies have followed aggressive acquisition strategies, most often buying into the US, sometimes using newly-minted Neuer Markt paper. Some are seeking through these acquisitions to both broaden their technology platform and acquire a product portfolio, hoping thereby to avoid the pitfalls of a narrow focus. It's too early to tell whether such a dual model will work. But the fact that Germany's young companies are finding their own approach to competing globally shows that the country's biotech initiative has already had some success.
BioPharmaceutical Europe

GPC Leads German Dealmaking

Germany's GPC Biotech AG has already signed two deals with pharmaceutical companies this year. Both partners are fellow Germans, but neither deal would have happened had GPC not chosen to make itself international through acquiring privately held US oncology company Mitotix Inc. last March.
BioPharmaceutical
See All

Company Information

  • Industry
  • Biotechnology
  • Pharmaceuticals
  • Therapeutic Areas
  • Cancer
  • Hepatic (Liver)
  • Alias(es)
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • Immune Pharmaceuticals Inc.
  • Senior Management
  • Larry G Stambaugh, Chmn., Pres. & CEO
    John Prunty, VP, Fin. & CFO
    Ben Tseng, PhD, VP, Research
  • Contact Info
  • Maxim Pharmaceuticals Inc.
    Phone: (858) 453-4040
    8899 University Center Ln.
    Ste. 400
    San Diego, CA 92122
    USA
Advertisement
Advertisement
UsernamePublicRestriction

Register